Diamyd Medical AB (publ) (STO: DMYD.B)
Sweden
· Delayed Price · Currency is SEK 16.42
-0.04 (-0.24%)
Aug 30, 2024, 5:29 PM CET
Diamyd Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 127.02 | 158.23 | 102.39 | 93.02 | 61.03 | 60.55 | Upgrade
|
| Other Revenue | 0.84 | 0.84 | 1.18 | 0.66 | - | - | Upgrade
|
| Revenue | 127.86 | 159.07 | 103.56 | 93.68 | 61.03 | 60.55 | Upgrade
|
| Revenue Growth (YoY) | -15.12% | 53.60% | 10.55% | 53.49% | 0.79% | 75.16% | Upgrade
|
| Cost of Revenue | 15.31 | 15.16 | 15.02 | 11.73 | 3.43 | 4.41 | Upgrade
|
| Gross Profit | 112.55 | 143.91 | 88.54 | 81.95 | 57.6 | 56.13 | Upgrade
|
| Selling, General & Admin | 75.95 | 79.35 | 68.19 | 52.85 | 47.31 | 39.08 | Upgrade
|
| Other Operating Expenses | -0.04 | -0.04 | -0.1 | 0.15 | -0.31 | 3.51 | Upgrade
|
| Operating Expenses | 87.73 | 89.03 | 74.72 | 58.77 | 52.44 | 46.09 | Upgrade
|
| Operating Income | 24.82 | 54.88 | 13.82 | 23.18 | 5.16 | 10.05 | Upgrade
|
| Interest Expense | -2.26 | -2.26 | -0.34 | - | -0.99 | -0.4 | Upgrade
|
| Interest & Investment Income | 2.23 | 2.89 | 0.06 | 0.06 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1.62 | -0.65 | 3.33 | 1.37 | 0.64 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | -0 | - | Upgrade
|
| EBT Excluding Unusual Items | 23.16 | 54.85 | 16.87 | 24.6 | 4.81 | 9.67 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -2.66 | - | Upgrade
|
| Other Unusual Items | - | - | -8.87 | - | - | - | Upgrade
|
| Pretax Income | 23.16 | 54.85 | 8 | 24.6 | 2.15 | 9.67 | Upgrade
|
| Income Tax Expense | 5.91 | -6.65 | -3.2 | -0.17 | -4.3 | 0.12 | Upgrade
|
| Net Income | 17.25 | 61.5 | 11.19 | 24.78 | 6.45 | 9.55 | Upgrade
|
| Net Income to Common | 17.25 | 61.5 | 11.19 | 24.78 | 6.45 | 9.55 | Upgrade
|
| Net Income Growth | -69.73% | 449.55% | -54.83% | 284.39% | -32.51% | - | Upgrade
|
| Shares Outstanding (Basic) | 65 | 65 | 65 | 65 | 65 | 63 | Upgrade
|
| Shares Outstanding (Diluted) | 65 | 65 | 65 | 65 | 65 | 63 | Upgrade
|
| Shares Change (YoY) | - | - | - | 0.58% | 3.15% | 1.88% | Upgrade
|
| EPS (Basic) | 0.26 | 0.94 | 0.17 | 0.38 | 0.10 | 0.15 | Upgrade
|
| EPS (Diluted) | 0.26 | 0.94 | 0.17 | 0.38 | 0.10 | 0.15 | Upgrade
|
| EPS Growth | -69.73% | 449.55% | -54.83% | 282.19% | -34.58% | - | Upgrade
|
| Free Cash Flow | 31.25 | 57.31 | -3.86 | 44.15 | 2.32 | 8.95 | Upgrade
|
| Free Cash Flow Per Share | 0.48 | 0.88 | -0.06 | 0.67 | 0.04 | 0.14 | Upgrade
|
| Gross Margin | 88.03% | 90.47% | 85.50% | 87.48% | 94.38% | 92.71% | Upgrade
|
| Operating Margin | 19.41% | 34.50% | 13.35% | 24.74% | 8.46% | 16.60% | Upgrade
|
| Profit Margin | 13.49% | 38.66% | 10.81% | 26.45% | 10.56% | 15.77% | Upgrade
|
| Free Cash Flow Margin | 24.44% | 36.03% | -3.73% | 47.13% | 3.80% | 14.78% | Upgrade
|
| EBITDA | 30.45 | 58.41 | 16.63 | 24.94 | 7.56 | 13.55 | Upgrade
|
| EBITDA Margin | 23.81% | 36.72% | 16.06% | 26.62% | 12.38% | 22.37% | Upgrade
|
| D&A For EBITDA | 5.63 | 3.53 | 2.81 | 1.76 | 2.39 | 3.5 | Upgrade
|
| EBIT | 24.82 | 54.88 | 13.82 | 23.18 | 5.16 | 10.05 | Upgrade
|
| EBIT Margin | 19.41% | 34.50% | 13.35% | 24.74% | 8.46% | 16.60% | Upgrade
|
| Effective Tax Rate | 25.52% | - | - | - | - | 1.20% | Upgrade
|
| Revenue as Reported | 131.84 | 164.95 | 110.13 | 96.25 | 65.65 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.